Fluvoxamine and perphenazine for psychosis in Alzheimer's disease: pharmacokinetic considerations.
Baumann
P
P
Eap
C B
CB
Zullino
D F
DF
D000368:Aged; D000544:Alzheimer Disease / Q000097:blood* / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D016666:Fluvoxamine / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006801:Humans; D010546:Perphenazine / Q000493:pharmacokinetics* / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000097:blood* / Q000188:drug therapy; D016896:Treatment Outcome
D010546:Perphenazine; D016666:Fluvoxamine